Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.

Clinical and experimental immunology - 12 Nov 2024

Woods Elena, Mena Adriana, Sierpinska Sophie, Carr Emily, Sttar Bioresource, Hagan Richard, Crowley John, Bergin Colm, Clark David, Brophy Caroline, Macallan Derek, Gardiner Clair M

Abstract excerpt

The recent pandemic was caused by the emergence of a new human pathogen, SARS-CoV-2. While the rapid development of many vaccines provided an end to the immediate crisis, there remains an urgent need to understand more about this new virus and what constitutes a beneficial immune response in terms of successful resolution of infection. Indeed, this is key for development of vaccines that provide long lasting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferons

Share to Interleukins

Share to Polymorphism, Single Nucleotide

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 38953458
DOI: 10.1093/cei/uxae047
PMCID: PMC11557148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.PMID 38953458Read ↗

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patientsSemantic proximity Read ↗

IFNL3/4 polymorphisms as a two-edged sword: An association with COVID-19 outcome.Semantic proximity Read ↗

The interferon landscape along the respiratory tract impacts the severity of COVID-19Semantic proximity Read ↗

Pegylated-interferon-λ treatment-induced peripheral interferon stimulated genes are associated with SARS-CoV-2 viral load decline despite delayed T cell response in older individualsSemantic proximity Read ↗

The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.Semantic proximity Read ↗

Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients.Semantic proximity Read ↗

Altered Transcript Levels of Cytokines in COVID-19 PatientsSemantic proximity Read ↗

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infectionsSemantic proximity Read ↗

Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.Semantic proximity Read ↗

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational StudySemantic proximity Read ↗

IFNL4 genetic variant can predispose to COVID-19Semantic proximity Read ↗

The Role of Type III Interferons in Hepatitis C Virus Infection and TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.